menu search

alvotech to report financial results for the first half of 2023 on august 30, 2023, and host business update conference call on august 31, 2023, at 8:00 am et

alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of bio...

August 22, 2023, 9:15 am

Bragar eagel & squire, p.c. is investigating xponential, franchise group, alvotech, and fmc and encourages investors to contact the firm

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

August 12, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating xponential, franchise group, alvotech, and sanmina and encourages investors to contact the firm

NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

August 1, 2023, 1:00 am

Teva pharmaceuticals and alvotech expand biosimilars partnership

Teva Pharmaceuticals Industries Ltd. TEVA, +0.47% and alvotech ALVO, +0.51% announced Monday that they ...

July 24, 2023, 8:47 am

Why shares of alvotech are jumping friday

alvotech specializes in biosimilar medicines. The company received a complete response letter from the ...

June 30, 2023, 12:59 pm

Bragar eagel & squire, p.c. is investigating zai lab, hayward, ascendis, and alvotech and encourages investors to contact the firm

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 26, 2023, 1:00 am

Bragar eagel & squire, p.c. is investigating c3.ai, ascendis, alvotech, and shift4 and encourages investors to contact the firm

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 20, 2023, 1:00 am

alvotech: precarious cash position dilutes special situation opportunity

alvotech has a resolvable CRL. This took down the stock, but when resolved, that could create a quick s...

June 8, 2023, 3:43 pm

Bragar eagel & squire, p.c. is investigating rh, alvotech, and triplepoint and encourages investors to contact the firm

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

June 5, 2023, 1:00 am

Alvo, alvow loss alert: rosen, national trial counsel, encourages alvotech investors to inquire about securities class action investigation – alvo, alvow

NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities...

May 30, 2023, 6:35 pm

alvotech alert: bragar eagel & squire, p.c. is investigating alvotech on behalf of alvotech stockholders and encourages investors to contact the firm

NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potenti...

May 4, 2023, 1:00 am

alvotech: company investigated by the portnoy law firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 19, 2023 (GLOBE NEWSWIRE) — The Portnoy...

April 20, 2023, 3:44 am

Investigation of alvotech (alvo) announced by holzer & holzer, llc

ATLANTA, April 18, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether alvotech (�...

April 18, 2023, 9:10 pm

alvotech (alvo) declines on crl for humira's biosimilar candidate

alvotech's shares decline as it receives a complete response letter for biosimilar candidate, AVT02, tr...

April 14, 2023, 3:12 pm

alvotech to present clinical study data for avt04, a proposed biosimilar to stelara®, at 2023 american academy of dermatology (aad) annual meeting

alvotech ( NASDAQ: ALVO ), a global biotech company specializing in the development and manufacture of ...

March 17, 2023, 9:10 am

alvotech announces webcast of 2022 full year financial results at 8:00 am et on march 2, 2023

REYKJAVIK, Iceland, Feb. 28, 2023 (GLOBE NEWSWIRE) -- alvotech (NASDAQ: ALVO), a global biotech company...

February 27, 2023, 7:15 pm

Why shares of alvotech jumped this week

The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe....

December 8, 2022, 1:29 pm

alvotech (alvo) q2 2022 earnings call transcript

alvotech (NASDAQ:ALVO ) Q2 2022 Earnings Conference Call September 1, 2022 8:00 AM ET Company Participa...

September 1, 2022, 2:16 pm

alvotech to participate in two upcoming investor conferences in september 2022

REYKJAVIK, Iceland and NEW YORK, Aug. 24, 2022 (GLOBE NEWSWIRE) -- alvotech (NASDAQ: ALVO), a global bi...

August 24, 2022, 4:00 am


Search within

Pages Search Results: